发明申请
- 专利标题： Salmeterol superfine formulation
- 专利标题（中）： 沙美特罗超细配方
-
申请号： US10531867申请日： 2003-06-18
-
公开(公告)号： US20060120966A1公开(公告)日： 2006-06-08
- 发明人: Tanya Church , David Lewis , David Ganderton , Brian Meakin , Gaetano Brambilla
- 申请人： Tanya Church , David Lewis , David Ganderton , Brian Meakin , Gaetano Brambilla
- 申请人地址： IT Parma 43100
- 专利权人： Chiesi Farmaceutici S.p.A.
- 当前专利权人： Chiesi Farmaceutici S.p.A.
- 当前专利权人地址： IT Parma 43100
- 优先权： EP020235891 20021023
- 国际申请： PCT/EP03/06444 WO 20030618
- 主分类号： A61L9/04
- IPC分类号： A61L9/04 ; A61K31/573 ; A61K31/4745 ; A61K31/46 ; A61M11/00
摘要：
The present invention relates to a pharmaceutical formulation for use in the administration of a long-acting β2-agonist by inhalation. In particular this invention relates to a chemically stable, highly efficient salmeterol HFA solution formulation to be administered by pressurised metered dose inhalers (pMDIs) characterized by a deep lung penetration. The invention also relates to methods for the preparation of said formulation and to its use in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
公开/授权文献
- US08088362B2 Salmeterol superfine formulation 公开/授权日：2012-01-03
信息查询
IPC分类:
